Skip to main content
OpenTrials
Completed

NCT Number: NCT05026437

CASUS vs. APACHE II in Predicting Mortality After Coronary Artery Bypass Grafting

The study seeks to determine the value of CASUS in predicting mortality as compared with APACHE II scoring system among patients undergoing coronary artery bypass grafting.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronary Artery Bypass Grafting Mortality

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey (Türkiye)

Loading trial locations.

About this study

Patients undergoing coronary artery bypass grafting will prospectively studied after the admission to the cardiac intensive care unit. Data on the preoperative condition, intraoperative parameters, and postoperative course will collected. CASUS and APACHE II scores will calculated on the first postoperative day. Clinical outcomes are defined as 7-day mortality, 30-day mortality and morbidity. Morbidity includes variables such as length of stay in the cardiac surgical intensive care unit and in the hospital.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Undergoing coronary artery bypass grafting
  • Over 18 years of age
  • Staying at least 24 hours in the cardiac intensive care unit

Exclusion criteria

  • Emergency surgery

Treatment and study plan

Cardiac surgery score and APACHE II scoring

Other

Cardiac surgery score and APACHE II will calculated on the first postoperative day.

Primary outcomes

  1. Mortality at 7 days

    Time frame: 7 days

    Mortality in the first 7 days after surgery

  2. Mortality at 30 days

    Time frame: 30 days

    Mortality in the first 30 days after surgery

Secondary outcomes

  1. Length of stay in the cardiac intensive care unit

    Time frame: Up to 3 months (Through study completion)

    Only the length of the initial stay in the cardiac intensive care unit up to 3 months

  2. Length of the stay in the hospital

    Time frame: Up to 3 months (Through study completion)

    It includes the period from surgery to discharge

Sponsors and collaborators

Lead sponsor

Antalya Training and Research Hospital

Other Gov

Collaborators

  • Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
  • Haydarpasa Numune Training and Research Hospital

Registry information

Official study title

The Value of CASUS vs. APACHE II in Predicting Mortality Among Patients Undergoing Coronary Artery Bypass Grafting

Acronym: CASUS

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Aug 30, 2021
Registry last updated
Aug 30, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.